Key priority area
Improve access to neoadjuvant therapy, including through clinical trials, in pancreatic cancer
Strategies and activities
Each key priority area has supporting strategies and associated activities for implementation in the short, medium or long term that have been identified to achieve the priority. Click on the strategies below to explore these in more detail.
Strategy
Establish routine access to neoadjuvant therapy
Activities
Short term
Promote awareness of the benefits of chemotherapy treatment options, including neoadjuvant therapy
Medium term
Design and implement standardised approaches for access to neoadjuvant therapy including through clinical trials, leveraging technology and innovation